matsky reaction of allyl bromoacetate. Deprotection of
the Boc group of 3 with 4 N HCl-dioxane followed
by carbonyldiimidazole (CDI)/4-(dimethylamino)pyridine
(DMAP)-mediated cyclization of the resulting deprotected
compound afforded the S-MBzl oxazolidinone 4. Acylation
of lithiated 4 with Fmoc-Gly-OH in the presence of pivaloyl
chloride (Piv-Cl) and Et3N gave the Fmoc-glycyloxazolidi-
none 5a. For attachment of the acyloxazolidinone to the resin,
allyl ester on 5a was quantitatively removed by treatment
with Pd(PPh3)4 in CHCl3/AcOH/N-methylmorpholine (NMM)
(37:2:1, v/v).16
Fmoc-glycyloxazolidinone such as 6a can be applicable to
the N-S acyl-transfer-mediated methodology, extensive
efforts are in progress in our laboratory to develop depro-
tection conditions suitable for chiral C-terminal aminoacy-
lated oxazolidinones.
Next, to evaluate the practical usefulness of 6a in
application to the NCL-mediated preparation of peptides, we
undertook the synthesis of hBNP32-NH2 14. The peptide
chain assembly for the peptide thioester precursor fragment
9 (corresponding to hBNP32-NH2 (1-9)) was conducted
using the Fmoc-Rink linker-Leu resin, on which Fmoc-
glycyloxazolidinone 6a and Fmoc-amino acids were suc-
cessively coupled with the aid of diisopropylcarbodiimide
(DIPCDI)-HOBt (or 1-hydroxy-7-azabenzotriazole (HOAt)).
Treatment with Aimoto’s reagent cocktail (20 min reaction/
each step) was utilized for the removal of Fmoc groups.
Amino acid analysis of the hydrolysate resulting from the
completed resin 8 revealed that the peptide chain assembly
proceeded efficiently without significant decomposition of
the acyloxazolidinone linkage.22 Treatment of the completed
resin 8 with TFA-thioanisole-m-cresol-Et3SiH-H2O (80:
5:5:5:5, v/v) at room temperature for 2 h, followed by HPLC
purification, gave the S-protected peptidyloxazolidinone 9
as a thioester precursor in 22% yield.
The resulting carboxylic acid 6a can be coupled to an
amino-functionalized resin using standard peptide coupling
conditions. Before elongation of the peptide chain, the
stability of the acyloxazolidinone linkage toward basic
treatment needed for Fmoc-removal was examined. For this
purpose, Rink amide linker-functionalized resin possessing
an internal standard amino acid (Leu) for amino acid analysis
following acid hydrolysis was prepared by successive
coupling of Fmoc-Leu-OH and Fmoc-Rink linker17 on the
amino methyl resin. On this resin was coupled the Boc-
glycyloxazolidinone 6b, which was prepared by reactions
identical to those used for 6a. Treatment of the resulting resin
7b with basic reagent systems followed by amino acid
analysis after acid hydrolysis indicated that treatment with
20% piperidine in N,N-dimethylformamide (DMF) (standard
Fmoc deprotection) partially induced the decomposition of
the amide linkage (ca. 20% of the linkage was broken after
5 h treatment). On the other hand, the use of Aimoto’s
reagent mixture18 consisting of 1-methylpyrrolidine-
hexamethyleneimine-1-hydroxybenzotriazole (HOBt) (25%
(v/v)-2% (v/v)-3% (w/v) in 1-methylpyrrolidin-2-one
(NMP)-dimethyl sulfoxide (DMSO) (1:1)) proved to be
compatible with the resin in the presence of the acyloxazo-
lidinone linkage.19 This basic reagent system has been
successfully applied to the Fmoc-based synthesis of peptide
thioesters without affecting thioester linkages. However, one
potential limitation with the use of this procedure in the
synthesis of thioesters is racemization of chiral thioester-
linked C-terminal amino acids.20 This is the case with
aminoacylated oxazolidinones.21 At this stage, since only
The resulting peptidyloxazolidinone was then subjected
to the NCL-mediated synthesis of hBNP32-NH2 (Scheme
2). HPLC-purified S-protected derivative 9 was treated with
Scheme 2
(11) For nucleophilic involvement of hydroxy group leading to N-O
acyl transfer, see: Bew, S. P.; Bull, S. D.; Davies, S. G.; Savory, E. D.;
Watkin, D. J. Tetrahedron 2002, 58, 9387-9401 and references cited herein.
(12) A 32-mer disulfide-containing peptide, human brain natriuretic
peptide derivative (amide form: hBNP32-NH2 14), was selected as model
synthetic peptide. For hBNP32, see: Kambayashi, Y.; Nakao, K.; Mukoya-
ma, M.; Saito, Y.; Ogawa, Y.; Shiono, S.; Inoue, K.; Yoshida, M.; Imura,
H. FEBS Lett. 1990, 259, 341-345.
(13) Olliver, N.; Behr, H.-B.; Ei-Mahdi, O.; Blanpain, A.; Melnyk, O.
Org. Lett. 2005, 7, 2647-2650.
0.5 M trimethylsilyl bromide (TMSBr)-thioanisole (1:1) in
TFA and m-cresol23 at -10 °C for 1 h to afford the
S-deprotected peptidyloxazolidinone 10, which was then
purified by HPLC. NCL of the purified 10 with the
(14) Kawakami, T.; Sumida, M.; Nakamura, K.; Vorherr, T.; Aimoto,
S. Tetrahedron Lett. 2005, 46, 8805-8807.
(15) Wang, G.; Mahesh, U.; Chen, G. Y. J.; Yao, S. Q. Org. Lett. 2003,
5, 737-740 and references cited herein.
(16) Kates, S. A.; Daniels, S. B.; Sole, N. A.; Barany, G.; Albericio, F.
In Peptides: Chemistry, Structure and Biology; Hodges, R. S., Smith, J.
A., Eds.; ESCOM: Leiden, 1994; pp 113-115.
(20) Hasegawa, K.; Sha, Y. L.; Bang, J. K.; Kawakami, T.; Akaji, K.;
Aimoto, S. Lett. Peptide Sci. 2002, 8, 277-284.
(21) Oxazolidinone derivative 4 was derivatized with Fmoc-L-Ala-OH.
Then, treatment of the resulting Fmoc-L-Ala-linked derivative with the
Aimoto’s reagent cocktail afforded the mixture of H-L-Ala- or H-D-Ala-
linked oxazolidinone derivative. Results of quantitative HPLC analysis of
the reaction mixture are shown as a graph in the Supporting Information.
(17) Bernatowicz, M. S.; Daniels, S. D.; Kster, H. Tetrahedron Lett. 1989,
30, 4645-4648.
(18) Li, X. Q.; Kawakami, T.; Aimoto, S. Tetrahedron Lett. 1998, 39,
8669-8672.
(19) Treatment of 7b with Aimoto’s reagent cocktail for 5 h induced ca.
3% cleavage of the linkage. See the Supporting Information.
Org. Lett., Vol. 8, No. 3, 2006
469